Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and pharmacies. They’ve figured out how to skim profit from every single one of ...

Investors in ARS Pharmaceuticals lost more than 23% of their investment value in after-hours trading on June 24, 2026, after the Company disclosed that Neffy® -- its flagship epinephrine nasal spray - ...

The Division of Economic and Health Policy Research (Division) conducts independent research on competition in health insurance, pharmacy benefit manager (PBM) and hospital markets. A key question of ...

Ozempic lists for roughly $969 in the United States and around €59 in Germany — the same pen, the same molecule, made in the same Danish factory. The reason winds back to a Nobel laureate's 1922 trip ...

Publications are communication focused documents, booklets, forms and references. The focus of these documents are to relay helpful information about the UT System, employee benefit information, ...